Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Tournier

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|June 3, 2006
Resident CD11c+ lung cells are impaired by anthrax toxins after spore infectionAurelie Cleret, Anne Quesnel-Hellmann, Jacques Mathieu, et al.
Clinical Pharmacokinetics|September 17, 2025
Modeling Whole-Body Dynamic PET Microdosing Data to Predict the Whole-Body Pharmacokinetics of Glyburide in HumansLéa Comin, Solène Marie, Moreno Ursino, et al.
The International Journal of Neuropsychopharmacology|November 6, 2009
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)Nicolas Tournier, Lucie Chevillard, Bruno Megarbane, et al.
Vaccine|May 15, 2007
Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccinesAudrey Ferrier-Rembert, Robert Drillien, Jean-Nicolas Tournier, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Dynamics of rapid spore capture by dendritic cells in the lung alveolusDaniel Fiole, Julien Douady, Jean-Claude Vial, et al.
Vaccine|March 14, 2008
Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccineAudrey Ferrier-Rembert, Robert Drillien, Jean-Nicolas Tournier, et al.
Clinical Pharmacology and Therapeutics|December 1, 2023
Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor ApproachMengyue Yin, Ankit Balhara, Solène Marie, et al.
Vaccines|September 23, 2022
Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic ControlMarie Mura, Fabrice Simon, Vincent Pommier de Santi, et al.
Microorganisms|February 24, 2024
Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?Emilie Tessier, Laurence Cheutin, Annabelle Garnier, et al.
Nuclear Medicine and Biology|January 14, 2020
Automated two-step manufacturing of [<sup>11</sup>C]glyburide radiopharmaceutical for PET imaging in humansFabien Caillé, Philippe Gervais, Sylvain Auvity, et al.
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|June 3, 2006
Resident CD11c+ lung cells are impaired by anthrax toxins after spore infectionAurelie Cleret, Anne Quesnel-Hellmann, Jacques Mathieu, et al.
Clinical Pharmacokinetics|September 17, 2025
Modeling Whole-Body Dynamic PET Microdosing Data to Predict the Whole-Body Pharmacokinetics of Glyburide in HumansLéa Comin, Solène Marie, Moreno Ursino, et al.
The International Journal of Neuropsychopharmacology|November 6, 2009
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)Nicolas Tournier, Lucie Chevillard, Bruno Megarbane, et al.
Vaccine|May 15, 2007
Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccinesAudrey Ferrier-Rembert, Robert Drillien, Jean-Nicolas Tournier, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Dynamics of rapid spore capture by dendritic cells in the lung alveolusDaniel Fiole, Julien Douady, Jean-Claude Vial, et al.
Vaccine|March 14, 2008
Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccineAudrey Ferrier-Rembert, Robert Drillien, Jean-Nicolas Tournier, et al.
Clinical Pharmacology and Therapeutics|December 1, 2023
Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor ApproachMengyue Yin, Ankit Balhara, Solène Marie, et al.
Vaccines|September 23, 2022
Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic ControlMarie Mura, Fabrice Simon, Vincent Pommier de Santi, et al.
Microorganisms|February 24, 2024
Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?Emilie Tessier, Laurence Cheutin, Annabelle Garnier, et al.
Nuclear Medicine and Biology|January 14, 2020
Automated two-step manufacturing of [<sup>11</sup>C]glyburide radiopharmaceutical for PET imaging in humansFabien Caillé, Philippe Gervais, Sylvain Auvity, et al.
Pageof 20